Investor Relations

About

We are a development stage biopharmaceutical company focused on the development of oral small molecule drugs for major unmet medical needs in male and female health.

Our current product pipeline (with the respective status of development) consists of the following:

Androxal®
Male Reproductive Health

Proellex®
Female Reproductive Health

Read More...